TickerFacts.

NeuroPace Inc (NPCE): Share Repurchases

Annual figures by period end, from SEC filings.

$49.55M
Year ended 2025-12-31
$0
Trailing 12 months to 2026-06-30
2024-12-31: $02025-12-31: $49.55M$49.55M
2024-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$49.55Mn/a2026-03-03, From 2025-01-01
2024-12-31$0n/a2026-03-03, From 2024-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
NeuroPace Inc (NPCE)2025-12-31$49.55Mn/a
Anika Therapeutics, Inc. (ANIK)2025-12-31$9.48M-13.1%
Orasure Technologies Inc (OSUR)2025-12-31$15.04Mn/a
Delcath Systems, Inc. (DCTH)2025-12-31$6.00Mn/a
PRO DEX Inc (PDEX)2026-06-30$3.41M-2.7%
InfuSystem Holdings, Inc (INFU)2025-12-31$9.87M+736.4%
Meihua International Medical Technologies Co., Ltd. (MHUAF)2024-12-31$200.0Kn/a
Lemaitre Vascular Inc (LMAT)2025-12-31$1.82M+5.9%
Utah Medical Products Inc (UTMD)2025-12-31$8.36M-58.2%

Compare NPCE, ANIK, OSUR, DCTH side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗